Molecular Characterization and In-Silico Analysis of the Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Gene of Canine Mammary Tumor. 2017

Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
Division of Biochemistry, Indian Veterinary Research Institute, Izatnagar, Bareilly-243122, Uttar Pradesh, India.

BACKGROUND Mammary tumors are the second most common tumors (after skin tumors) in female dogs (Canis lupus familiaris). Tissue Inhibitor of Metlloproteinases-3 (TIMP-3) is a matrix associated endogenous inhibitor of Matrix Metalloproteinases (MMPs). Cancer metastasis occurs as a result of imbalance between MMPs and TIMPs. TIMP-3 is involved significantly in regulation of MMPs as well as progression of canine mammary tumor. OBJECTIVE The present study was conducted to identify the structural and functional relationship between TIMP-3 and MMP which can aid in identifying the role of these proteins in canine mammary tumor. METHODS Molecular characterization of TIMP-3 protein was done by molecular biology techniques such as gene cloning and sequencing. The homology based model of TIMP-3 protein was created and verified with a variety of available computational techniques as well as molecular dynamics simulation. RESULTS The results indicated that predicted TIMP-3 protein structure of Canis lupus familiaris was reliable and more stable. The docking of TIMP-3 protein with MMP-2 and MMP-9 represents conformational structure of these two proteins which interact with each other but if misled canresult in the progression of tumor in canine. CONCLUSIONS The three dimensional structure of TIMP-3 was generated and its interactions with MMP-2 and MMP-9, demonstrates the role of key binding residues. Until now, no structural details were available for canine TIMP-3 proteins, hence this study will broaden the horizon towards understanding the structural and functional aspects of this proteins in canine.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015674 Mammary Neoplasms, Animal Tumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL). Animal Mammary Carcinoma,Mammary Carcinoma, Animal,Mammary Neoplasms,Neoplasms, Mammary,Animal Mammary Carcinomas,Animal Mammary Neoplasm,Animal Mammary Neoplasms,Carcinoma, Animal Mammary,Carcinomas, Animal Mammary,Mammary Carcinomas, Animal,Mammary Neoplasm,Mammary Neoplasm, Animal,Neoplasm, Animal Mammary,Neoplasm, Mammary,Neoplasms, Animal Mammary
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA
D059014 High-Throughput Nucleotide Sequencing Techniques of nucleotide sequence analysis that increase the range, complexity, sensitivity, and accuracy of results by greatly increasing the scale of operations and thus the number of nucleotides, and the number of copies of each nucleotide sequenced. The sequencing may be done by analysis of the synthesis or ligation products, hybridization to preexisting sequences, etc. High-Throughput Sequencing,Illumina Sequencing,Ion Proton Sequencing,Ion Torrent Sequencing,Next-Generation Sequencing,Deep Sequencing,High-Throughput DNA Sequencing,High-Throughput RNA Sequencing,Massively-Parallel Sequencing,Pyrosequencing,DNA Sequencing, High-Throughput,High Throughput DNA Sequencing,High Throughput Nucleotide Sequencing,High Throughput RNA Sequencing,High Throughput Sequencing,Massively Parallel Sequencing,Next Generation Sequencing,Nucleotide Sequencing, High-Throughput,RNA Sequencing, High-Throughput,Sequencing, Deep,Sequencing, High-Throughput,Sequencing, High-Throughput DNA,Sequencing, High-Throughput Nucleotide,Sequencing, High-Throughput RNA,Sequencing, Illumina,Sequencing, Ion Proton,Sequencing, Ion Torrent,Sequencing, Massively-Parallel,Sequencing, Next-Generation

Related Publications

Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
September 2001, The Journal of clinical investigation,
Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
June 1995, The Journal of biological chemistry,
Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
February 1996, The Journal of biological chemistry,
Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
December 1996, Carcinogenesis,
Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
January 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire,
Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
February 1994, Gene,
Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
January 2001, Methods in molecular biology (Clifton, N.J.),
Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
October 2002, Protein science : a publication of the Protein Society,
Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
January 1993, The Biochemical journal,
Pavan Kumar Yadav, and Brijesh Singh Yadav, and Padma Nibash Panigrahi, and Vijay Tripathi, and Navaneet Chaturvedi, and Meena Kataria
April 1998, The Journal of investigative dermatology,
Copied contents to your clipboard!